GO:0051765 inositol tetrakisphosphate kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051765 (inositol tetrakisphosphate kinase activity) catalyzes the ATP-dependent phosphorylation of inositol tetrakisphosphate to inositol pentakisphosphate.
• The reaction is a core step in the inositol phosphate metabolic network, which controls signaling, phosphate homeostasis, and protein interactions.
• ITPK1 is the best-characterized enzyme carrying this activity, and its structure and enzymology have been resolved in plants and other systems.
• Inositol 1,3,4,5-tetrakisphosphate, a product of related kinase reactions, acts as a negative regulator of platelet function.
• Loss or inhibition of inositol tetrakisphosphate kinase activity alters diphosphoinositol phosphate levels and cellular phosphate buffering.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the pathway's role in disease and cell signaling.
Description
Inositol tetrakisphosphate kinase activity (GO:0051765) is a molecular function that catalyzes the transfer of a phosphate group from ATP to an inositol tetrakisphosphate, yielding inositol pentakisphosphate and ADP. This reaction sits at a critical junction of the inositol phosphate signaling network, where soluble inositol polyphosphates act as second messengers, cofactors, and regulators of protein function. The enzyme activity was first distinguished biochemically in the late 1980s, when L-myo-inositol 1,4,5,6-tetrakisphosphate (3-hydroxy)kinase was identified in cell extracts. Since then, the ITPK family has expanded, with structural and enzymological studies revealing how different isoforms recognize inositol tetrakisphosphate substrates and couple catalysis to ATP binding. Researchers study GO:0051765 because it directly controls the balance between inositol tetrakisphosphate and inositol pentakisphosphate, two molecules that influence calcium signaling, platelet function, and phosphate sensing. Moreover, the activity is linked to diphosphoinositol phosphate metabolism, a process that buffers cellular phosphate stress and impacts cell survival. Understanding this activity at the molecular level is therefore essential for interpreting how cells translate extracellular signals into metabolic and transcriptional responses.
inositol tetrakisphosphate kinase activity At A Glance
| GO ID | GO:0051765 |
|---|---|
| GO term | inositol tetrakisphosphate kinase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | ATP-dependent phosphorylation of inositol tetrakisphosphate to inositol pentakisphosphate |
| Reaction | inositol tetrakisphosphate + ATP = inositol pentakisphosphate + ADP |
| Representative enzyme | ITPK1 (inositol-tris/tetrakisphosphate kinase 1) |
| Pathway context | Inositol phosphate metabolism and diphosphoinositol phosphate buffering |
| Related activity | Inositol trisphosphate kinase activity (overlapping substrate range in ITPK family) |
What Is GO:0051765?
Inositol tetrakisphosphate kinase activity is the catalytic function that uses ATP to add a phosphate group to an inositol tetrakisphosphate molecule, producing inositol pentakisphosphate and ADP. This definition follows the official GO:0051765 entry and reflects the conserved phosphotransferase chemistry observed across ITPK family enzymes.
Why Is inositol tetrakisphosphate kinase activity Important in Cell Biology?
GO:0051765 is important because it controls the cellular levels of inositol pentakisphosphate, a molecule that regulates protein interactions, phosphate homeostasis, and signaling cascades. The reaction also feeds into the diphosphoinositol phosphate pool, which buffers phosphate stress and influences cell survival. In platelets, related inositol tetrakisphosphate species act as negative regulators of activation, highlighting the physiological relevance of this kinase activity in hemostasis. Furthermore, structural studies of ITPK enzymes have made this activity a model for understanding how substrate specificity evolves within a small kinase family. For researchers, measuring or perturbing this activity provides a direct handle on inositol phosphate signaling and its downstream effects.
• Controls the balance between inositol tetrakisphosphate and inositol pentakisphosphate, key signaling molecules.
• Regulates diphosphoinositol phosphate levels, which buffer cellular phosphate stress.
• Influences platelet function through inositol 1,3,4,5-tetrakisphosphate as a negative regulator.
• Provides a structural paradigm for ITPK family substrate specificity and catalysis.
• Links inositol phosphate metabolism to protein kinase regulation, including casein kinase-2.
• Is a target for inhibitor development, as shown by biochemical characterization of ITPK1 inhibitors.
• Plays a role in plant and human cell signaling, making it relevant across species.
• Can be studied with CRISPR models to test causality in disease and development.
• Contributes to the broader inositol polyphosphate network that affects calcium signaling and membrane trafficking.
• Offers a measurable enzymatic readout for high-throughput screening and drug discovery.
Molecular Mechanism of inositol tetrakisphosphate kinase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the inositol tetrakisphosphate substrate and ATP in the right orientation.
ITPK family enzymes bind inositol tetrakisphosphate through a conserved ATP-binding pocket and a substrate specificity loop that positions the inositol ring for phosphoryl transfer. Structural studies of StITPK1 and AtITPK4 show that distinct residues in the active site determine whether the enzyme prefers inositol trisphosphate or inositol tetrakisphosphate as a substrate. This substrate discrimination is a key determinant of the reaction flux through GO:0051765.
Catalytic phosphoryl transfer
In simple terms: ATP donates a phosphate group to the inositol tetrakisphosphate, making inositol pentakisphosphate.
The catalytic step involves ATP-dependent transfer of the gamma-phosphate to the inositol tetrakisphosphate acceptor, producing inositol pentakisphosphate and ADP. Biochemical characterization of ITPK1 inhibitors confirms that the reaction follows a sequential mechanism requiring both substrates. The enzyme activity was originally defined using L-myo-inositol 1,4,5,6-tetrakisphosphate as a substrate, establishing the stereochemical preference of the kinase.
Product release and metabolic coupling
In simple terms: After making inositol pentakisphosphate, the enzyme releases it so it can be used elsewhere.
Inositol pentakisphosphate produced by GO:0051765 can be further phosphorylated or used as a precursor for diphosphoinositol phosphates. ITPK1 and inositol pentakisphosphate 2-kinase (IPK1) form a metabolic cassette that buffers diphosphoinositol phosphate levels in response to ATP availability. This coupling means that the activity of inositol tetrakisphosphate kinase is directly tied to cellular energy status and phosphate homeostasis.
Regulation by inositol phosphates and protein partners
In simple terms: Other inositol phosphates and partner proteins can turn the enzyme up or down.
Inositol phosphates can regulate protein kinases such as casein kinase-2, indicating that the products of GO:0051765 participate in feedback regulation of signaling enzymes. SHIP proteins, which hydrolyze phosphatidylinositol phosphates, also influence the inositol phosphate pool that feeds into this kinase activity. These interactions place inositol tetrakisphosphate kinase within a broader regulatory network that responds to extracellular signals.
Inhibitor sensitivity and pharmacological modulation
In simple terms: Small molecules can block the enzyme, which helps researchers study its function.
Biochemical and biophysical characterization of ITPK1 inhibitors has identified compounds that interfere with inositol tetrakisphosphate kinase activity. These inhibitors provide tools to probe the cellular consequences of reducing inositol pentakisphosphate production. Such pharmacological modulation complements genetic approaches and supports drug discovery efforts targeting this activity.
Key Genes Involved in GO:0051765 inositol tetrakisphosphate kinase activity
The genes and proteins below are directly implicated in inositol tetrakisphosphate kinase activity or its regulation, based on published biochemical, structural, and genetic studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITPK1 | Primary enzyme with inositol tetrakisphosphate kinase activity | Structural and enzymology studies; inhibitor development |
| ITPK4 | Outlier ITPK family member with distinct substrate specificity | Comparative structure-function analysis |
| IPK1 | Inositol pentakisphosphate 2-kinase that acts downstream of ITPK1 | Metabolic cassette buffering diphosphoinositol phosphates |
| ITPKA | Inositol trisphosphate 3-kinase that produces inositol tetrakisphosphate | Platelet function and signaling |
| ITPKB | Inositol trisphosphate 3-kinase isoform | Negative regulation of platelet function |
| ITPKC | Inositol trisphosphate 3-kinase C | Related kinase activity in immune signaling |
| SHIP1 | Phosphatidylinositol phosphatase affecting inositol phosphate pools | Regulation of inositol phosphate signaling |
| SHIP2 | Phosphatidylinositol phosphatase affecting inositol phosphate pools | Regulation of inositol phosphate signaling |
| CK2 | Casein kinase-2 regulated by inositol phosphates | Downstream effector of inositol phosphate signaling |
| StITPK1 | Plant ITPK1 ortholog with resolved crystal structure | Model for substrate specificity |
| AtITPK4 | Arabidopsis ITPK4 outlier with distinct enzymology | Evolution of ITPK family |
| ITPK1 (human) | Human enzyme with inositol tetrakisphosphate kinase activity | Inhibitor characterization and disease relevance |
| IPK1 (human) | Human inositol pentakisphosphate 2-kinase | Phosphate homeostasis |
| ITPKA (platelet) | Platelet isoform producing inositol tetrakisphosphate | Hemostasis and thrombosis |
| ITPKB (platelet) | Platelet isoform producing inositol tetrakisphosphate | Hemostasis and thrombosis |
| ITPKC (platelet) | Platelet isoform producing inositol tetrakisphosphate | Hemostasis and thrombosis |
| SHIP1/2 (immune) | Regulators of inositol phosphate pools in immune cells | Immune signaling |
How Is inositol tetrakisphosphate kinase activity Regulated?
Inositol tetrakisphosphate kinase activity is regulated at multiple levels. The ITPK1-IPK1 metabolic cassette responds to ATP availability, meaning that cellular energy status directly influences flux through GO:0051765. Inositol phosphates themselves can regulate protein kinases such as casein kinase-2, creating feedback loops that modulate the pathway. SHIP proteins alter the availability of phosphatidylinositol phosphates that feed into inositol phosphate pools, indirectly affecting the substrate supply for this kinase activity. Additionally, inhibitor studies show that small molecules can acutely modulate the enzyme, suggesting that pharmacological regulation is feasible.
inositol tetrakisphosphate kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITPK1 | Metabolic stress and phosphate homeostasis | ITPK1 knockout cell line |
| ITPKA | Platelet dysfunction and thrombosis | Platelet-specific ITPKA knockout mouse |
| ITPKB | Platelet dysfunction and thrombosis | Platelet-specific ITPKB knockout mouse |
| SHIP1 | Immune dysregulation | SHIP1 knockout immune cells |
| CK2 | Cancer cell signaling | CK2 point-mutation knock-in |
Platelet function and thrombosis
Inositol 1,3,4,5-tetrakisphosphate, a product of related kinase reactions, acts as a negative regulator of platelet function, and enzymes such as ITPKA and ITPKB influence this process. Dysregulation of inositol tetrakisphosphate kinase activity could therefore alter platelet activation and thrombus formation.
Phosphate homeostasis and metabolic stress
The ITPK1-IPK1 cassette buffers diphosphoinositol phosphate levels, which are critical for adapting to phosphate stress. Loss of inositol tetrakisphosphate kinase activity may impair this buffering capacity, linking the enzyme to metabolic disorders.
Cancer and cell signaling
Inositol phosphate signaling pathways are frequently altered in cancer, and enzymes that produce inositol pentakisphosphate can influence cell survival and proliferation. Inhibitors of ITPK1 have been characterized, providing a starting point for exploring this activity as a therapeutic target.
Immune regulation
SHIP proteins regulate inositol phosphate pools in immune cells, and their activity affects signaling downstream of immune receptors. Because inositol tetrakisphosphate kinase activity depends on substrate availability, changes in SHIP function could indirectly modulate this pathway in immune disorders.
From inositol tetrakisphosphate kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ITPK1 reduce inositol pentakisphosphate levels? | ITPK1 knockout cell line |
| How does a catalytic point mutation affect enzyme activity? | Point-mutation knock-in of ITPK1 |
| Can tagged ITPK1 be used to monitor localization? | Tagged knock-in of ITPK1 |
| Does overexpression of ITPK1 alter phosphate buffering? | ITPK1 overexpression cell line |
| Which substrates are preferred by ITPK4? | ITPK4 knockout and rescue with point mutants |
| Does ITPKA/B loss affect platelet activation? | Platelet-specific knockout mouse |
How to Study the inositol tetrakisphosphate kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Kinase assay | Enzymatic conversion of inositol tetrakisphosphate to inositol pentakisphosphate | Inhibitor screening and kinetics |
| Crystallography | Three-dimensional structure of ITPK enzymes | Substrate specificity and mechanism |
| Mass spectrometry | Cellular levels of inositol phosphates | Pathway flux and phosphate buffering |
| CRISPR knockout | Loss-of-function effects on pathway | Causality testing |
| Point-mutation knock-in | Effect of specific catalytic residues | Mechanistic dissection |
| Overexpression | Gain-of-function effects on metabolite levels | Pathway amplification |
| Platelet aggregation assay | Platelet function in response to agonists | Hemostasis research |
| Protein interaction assays | Binding partners of ITPK enzymes | Regulatory network mapping |
Enzymatic assays for kinase activity
In vitro kinase assays using radiolabeled ATP or fluorescent substrates can directly measure inositol tetrakisphosphate kinase activity. These assays are used to determine kinetic parameters and to test inhibitors.
Structural biology (crystallography and modeling)
Crystal structures of StITPK1 and AtITPK4 have revealed the active-site architecture that governs substrate specificity. Such structural work guides mutagenesis and inhibitor design.
Mass spectrometry of inositol phosphates
Mass spectrometry-based methods can quantify inositol pentakisphosphate and diphosphoinositol phosphates in cells, providing a readout of pathway flux. This approach is essential for linking enzyme activity to cellular metabolite levels.
CRISPR-based genetic perturbation
Knockout, point-mutation, and knock-in models allow researchers to test the causal role of specific residues and genes in inositol tetrakisphosphate kinase activity. These models can be combined with metabolic profiling to assess downstream effects.
How CRISPR Can Be Used to Study GO:0051765 inositol tetrakisphosphate kinase activity
Knockout
CRISPR knockout of ITPK1 or related genes eliminates inositol tetrakisphosphate kinase activity, allowing researchers to measure the consequences for inositol pentakisphosphate and diphosphoinositol phosphate levels. Such models are used to test whether the activity is required for phosphate stress responses.
Point Mutation
Point-mutation knock-in of catalytic residues in ITPK1 can abolish or alter kinase activity without removing the protein, providing a precise way to separate catalytic function from scaffolding roles. These models are valuable for validating inhibitor specificity.
Knock-in
Tagged knock-in of ITPK1 enables live-cell imaging and proteomic analysis of the enzyme, revealing its localization and interaction partners. This approach helps connect the activity to specific cellular compartments.
Overexpression
Overexpression of ITPK1 or ITPK4 increases flux through GO:0051765, which can be used to test downstream effects on signaling and metabolism. Overexpression models are also useful for producing recombinant enzyme for structural studies.
How EDITGENE Supports inositol tetrakisphosphate kinase activity Research
Researchers studying inositol tetrakisphosphate kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or metabolic phenotype. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for inositol tetrakisphosphate kinase activity research.
Frequently Asked Questions About inositol tetrakisphosphate kinase activity
What is inositol tetrakisphosphate kinase activity?
It is the enzymatic activity (GO:0051765) that transfers a phosphate from ATP to inositol tetrakisphosphate, producing inositol pentakisphosphate and ADP.
What genes are involved in inositol tetrakisphosphate kinase activity?
ITPK1 is the primary gene, with ITPK4, IPK1, and related ITPK family members also contributing to the pathway.
What is the reaction catalyzed by GO:0051765?
The reaction is inositol tetrakisphosphate + ATP = inositol pentakisphosphate + ADP.
Which enzyme carries inositol tetrakisphosphate kinase activity?
ITPK1 (inositol-tris/tetrakisphosphate kinase 1) is the best-characterized enzyme with this activity.
How is inositol tetrakisphosphate kinase activity regulated?
It is regulated by ATP availability, inositol phosphate feedback, and protein partners such as SHIP and CK2.
What diseases are linked to inositol tetrakisphosphate kinase activity?
It has been linked to platelet function, phosphate homeostasis, cancer signaling, and immune regulation.
Can CRISPR be used to study inositol tetrakisphosphate kinase activity?
Yes, knockout, point-mutation, knock-in, and overexpression models are all used to dissect the pathway.
What methods measure inositol tetrakisphosphate kinase activity?
Kinase assays, mass spectrometry, crystallography, and CRISPR-based perturbation are commonly used.
Is there a known inhibitor of inositol tetrakisphosphate kinase activity?
Yes, biochemical and biophysical characterization has identified ITPK1 inhibitors.
What is the role of inositol pentakisphosphate produced by this activity?
It serves as a precursor for diphosphoinositol phosphates and regulates protein interactions and phosphate buffering.
Conclusion
Inositol tetrakisphosphate kinase activity (GO:0051765) is a central enzymatic step in inositol phosphate metabolism, controlling the production of inositol pentakisphosphate and influencing phosphate homeostasis, platelet function, and signaling. Structural and biochemical studies have defined the catalytic mechanism and substrate specificity of ITPK family enzymes, while inhibitor development offers pharmacological tools. CRISPR-based models are essential for testing causality and for exploring therapeutic opportunities. Continued research on this activity will clarify its roles in health and disease.
References
- 1. Ng MY et al.. 2025. Biochemical and biophysical characterization of inositol-tetrakisphosphate 1-kinase inhibitors.. J Biol Chem 301(3):108274 PMID: 39922495
- 2. Stephens LR et al.. 1988. L-myo-inositol 1,4,5,6-tetrakisphosphate (3-hydroxy)kinase.. Biochem J 249(1):283-92 PMID: 2829850
- 3. Whitfield HL et al.. 2024. Crystal Structure and Enzymology of Solanum tuberosum Inositol Tris/Tetrakisphosphate Kinase 1 (StITPK1).. Biochemistry 63(1):42-52 PMID: 38146842
- 4. Whitfield HL et al.. 2023. Diversification in the inositol tris/tetrakisphosphate kinase (ITPK) family: crystal structure and enzymology of the outlier AtITPK4.. Biochem J 480(6):433-453 PMID: 36896917
- 5. Authi KS et al.. 2024. Evidence that inositol 1,4,5-trisphosphate 3-kinase and inositol 1,3,4,5-tetrakisphosphate are negative regulators of platelet function.. Res Pract Thromb Haemost 8(1):102326 PMID: 38404940
- 6. Krystal G et al.. 1999. SHIPs ahoy.. Int J Biochem Cell Biol 31(10):1007-10 PMID: 10582334
- 7. Solyakov L et al.. 2004. Regulation of casein kinase-2 (CK2) activity by inositol phosphates.. J Biol Chem 279(42):43403-10 PMID: 15297462
- 8. Whitfield H et al.. 2020. An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels.. Biochem J 477(14):2621-2638 PMID: 32706850
